Trimetrexate and folinic acid: A valuable salvage option for Pneumocystis jirovecii pneumonia

AIDS

Volumn 23, Issue 10, 2009, Pages 1287-1290

  Short, Charlotte Eve S ^a,b   Gilleece, Yvonne C ^a   Fisher, Martin J ^a   Churchill, Duncan R ^a  

^a UK   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CLINDAMYCIN PLUS PRIMAQUINE; CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE PLUS TRIMETHROPRIM; FOLINIC ACID; TRIMETREXATE; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BLOOD TRANSFUSION; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG TREATMENT FAILURE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG LAVAGE; MALE; MOUTH ULCER; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; DRUG EVALUATION; DRUG THERAPY, COMBINATION; FEMALE; HIV-1; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; TRIMETREXATE;

EID: 67651042940     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832d0792     Document Type: Article

References (12)

1. Benfield T, Atzori C, Miller R, Helweg-Larsen J. Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia. J Acquir Immune Defic Syndr 2008; 48:63-67.
2. Wofsy CB. Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome. Rev Infect Dis 1987; 9 (Suppl 2):S184-S194.
3. Saffrin S, Finkelstein D, FeinbergJ, Frame P, Simpson G, Wu A, et al. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. Ann Intern Med 1996; 124:792-802.
4. Klein N, Duncanson F, Lennox T, Forszpaniak C, Sherer CB, Quentzel H, et al. Trimethoprim-sulfamethoxazole vs pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomised treatment trial. AIDS 1992; 6:301-305.
5. Allegra CJ, Kovacs JA, Drake JC, Swan JC, Chabner BA, Masur H. Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent. J Exp Med 1987; 165:926-931.
6. Sattler FR, Frame P, Davis R, Nichols L, Shelton B, Akil B, et al. Trimetrexate with leucovorin versus trimethoprim-sulfa-methoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031. J Infect Dis 1994; 170:165-172.
7. Sattler FR, Allegra CJ, Verdegem TD, Akil B, Tuazon CU, Hughlett C, et al. Trimetrexate-leucovorin dosage evaluation study for treatment of Pneumocystis carinii pneumonia. J Infect Dis 1990; 161:91-96.
8. Smego RA, Nagar S, Maloba B, Popara M. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia. Arch Intern Med 2001; 161:1529-1533.
9. Allegra CJ, Chabner BA, Tuazon CU, Ogata-Arakaki D, Baird B, Drake JC, et al. Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1987; 317:978-985.
10. Feinberg J, McDermott C, Nutter J. Trimetrexate (TMTX) salvage therapy for PCP in AIDS patients with limited therapeutic options. Int Conf AIDS 1992; 8:B136; (Abstract 3297).
11. NIH: Clinical Trials.gov [internet]. Maryland: U.S. National Institutes of Heath; (c1999-2008). NCT00000724;6 August 2008 [cited 2009 Mar 4]; [about 2 screens]. http://clinicaltrials.gov/ct2/show/NCT00000724.
12. Miller RF, Allen E, Copas A, Singer M, Edwards SG. Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax 2006; 61:716-721.